$5.92 Billion is the total value of Eventide Asset Management's 139 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 29.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $194,022,823 | +249.6% | 6,877,803 | +113.1% | 3.28% | +222.1% |
PANW | Sell | PALO ALTO NETWORKS INC | $181,570,772 | +5.8% | 710,621 | -17.3% | 3.07% | -2.5% |
EXAS | Buy | EXACT SCIENCES CORP | $175,378,344 | +38.5% | 1,867,714 | +0.0% | 2.96% | +27.6% |
ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $164,488,464 | +8.6% | 444,864 | +0.1% | 2.78% | +0.0% |
MTD | Sell | METTLER TOLEDO INTERNATIONAL | $157,259,078 | -22.0% | 119,895 | -9.1% | 2.66% | -28.2% |
TT | Buy | TRANE TECHNOLOGIES PLC | $150,953,103 | +4.0% | 789,256 | +0.1% | 2.55% | -4.2% |
GH | Buy | GUARDANT HEALTH INC | $143,507,952 | +226.5% | 4,008,602 | +113.8% | 2.42% | +200.9% |
DOCS | Sell | DOXIMITY INCcl a | $132,461,395 | -22.0% | 3,893,633 | -25.8% | 2.24% | -28.1% |
ARGX | Buy | ARGENX SEsponsored adr | $128,250,789 | +4.7% | 329,076 | +0.0% | 2.17% | -3.6% |
FLYW | Buy | FLYWIRE CORPORATION | $126,293,255 | +6.9% | 4,068,726 | +1.1% | 2.13% | -1.6% |
IDXX | Sell | IDEXX LABS INC | $120,844,071 | -6.3% | 240,615 | -6.7% | 2.04% | -13.7% |
WCN | Buy | WASTE CONNECTIONS INC | $115,690,401 | +2.8% | 809,420 | +0.0% | 1.96% | -5.3% |
ROP | Sell | ROPER TECHNOLOGIES INC | $113,864,018 | -15.8% | 236,822 | -22.8% | 1.92% | -22.4% |
POOL | Buy | POOL CORP | $105,581,794 | +15.0% | 281,822 | +5.1% | 1.78% | +5.9% |
LOW | Buy | LOWES COS INC | $101,222,613 | +13.0% | 448,483 | +0.1% | 1.71% | +4.1% |
GLBE | Sell | GLOBAL E ONLINE LTD | $100,849,099 | +12.0% | 2,463,339 | -11.8% | 1.70% | +3.2% |
HUBS | Buy | HUBSPOT INC | $94,929,645 | +24.1% | 178,409 | +0.0% | 1.60% | +14.3% |
MIRM | Buy | MIRUM PHARMACEUTICALS INC | $89,489,530 | +80.9% | 3,459,201 | +68.0% | 1.51% | +66.7% |
DHI | Buy | D R HORTON INC | $83,754,968 | +24.6% | 688,265 | +0.0% | 1.42% | +14.8% |
APTV | Buy | APTIV PLC | $82,523,727 | +2.2% | 808,343 | +12.3% | 1.40% | -5.9% |
NEP | Sell | NEXTERA ENERGY PARTNERS LP | $80,755,372 | -8.4% | 1,377,138 | -5.1% | 1.36% | -15.6% |
EVH | Buy | EVOLENT HEALTH INCcl a | $79,935,762 | +29.5% | 2,638,144 | +38.6% | 1.35% | +19.2% |
TTD | Buy | THE TRADE DESK INC | $77,732,586 | +27.1% | 1,006,638 | +0.2% | 1.31% | +17.1% |
LRCX | Buy | LAM RESEARCH CORP | $75,451,192 | +21.7% | 117,368 | +0.3% | 1.28% | +12.0% |
LAD | Buy | LITHIA MTRS INC | $74,287,991 | +158.6% | 244,280 | +94.6% | 1.26% | +138.3% |
KDNY | Buy | CHINOOK THERAPEUTICS INC | $74,035,340 | +122.2% | 1,927,000 | +33.9% | 1.25% | +104.7% |
KRTX | Buy | KARUNA THERAPEUTICS INC | $73,722,061 | +19.4% | 339,968 | +0.0% | 1.25% | +10.0% |
DV | Buy | DOUBLEVERIFY HLDGS INC | $73,357,856 | +30.2% | 1,884,837 | +0.9% | 1.24% | +20.0% |
CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $73,043,445 | +7.3% | 497,334 | +0.3% | 1.23% | -1.2% |
HZNP | Sell | HORIZON THERAPEUTICS PUB L | $70,936,467 | -18.8% | 689,708 | -13.8% | 1.20% | -25.2% |
DLO | Buy | DLOCAL LTD | $69,563,703 | -3.8% | 5,699,607 | +27.9% | 1.18% | -11.3% |
SWAV | Buy | SHOCKWAVE MED INC | $69,199,652 | +31.9% | 242,457 | +0.2% | 1.17% | +21.6% |
XMTR | Buy | XOMETRY INC | $67,578,814 | +55.5% | 3,190,690 | +9.9% | 1.14% | +43.3% |
SHLS | Buy | SHOALS TECHNOLOGIES GROUP INcl a | $62,787,169 | +26.7% | 2,456,462 | +12.9% | 1.06% | +16.7% |
TREX | Buy | TREX CO INC | $57,856,634 | +34.7% | 882,499 | +0.0% | 0.98% | +24.1% |
FIVN | Sell | FIVE9 INC | $57,171,490 | -25.8% | 693,408 | -34.9% | 0.97% | -31.6% |
COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $56,545,713 | -10.4% | 2,631,257 | +0.0% | 0.96% | -17.4% |
ENTG | Sell | ENTEGRIS INC | $56,260,654 | +13.8% | 507,676 | -15.8% | 0.95% | +4.9% |
MPWR | Buy | MONOLITHIC PWR SYS INC | $52,591,931 | +8.0% | 97,351 | +0.0% | 0.89% | -0.6% |
ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $51,357,395 | -38.8% | 575,432 | -26.5% | 0.87% | -43.6% |
ASML | Buy | ASML HOLDING N V | $50,216,478 | +6.6% | 69,288 | +0.1% | 0.85% | -1.8% |
DDOG | Buy | DATADOG INC | $48,783,986 | +35.6% | 495,873 | +0.1% | 0.82% | +24.8% |
CLDX | CELLDEX THERAPEUTICS INC NEW | $46,746,718 | -5.7% | 1,377,740 | 0.0% | 0.79% | -13.1% | |
SPT | Buy | SPROUT SOCIAL INC | $46,287,125 | -13.1% | 1,002,754 | +14.6% | 0.78% | -20.0% |
LNG | Buy | CHENIERE ENERGY INC | $45,889,765 | -3.3% | 301,193 | +0.0% | 0.78% | -10.9% |
COUR | Sell | COURSERA INC | $44,295,277 | +13.0% | 3,402,095 | -0.0% | 0.75% | +4.2% |
NVT | NVENT ELECTRIC PLC | $41,465,330 | +20.3% | 802,503 | 0.0% | 0.70% | +10.9% | |
LSCC | Sell | LATTICE SEMICONDUCTOR CORP | $41,112,292 | -16.1% | 427,941 | -16.6% | 0.70% | -22.7% |
COGT | Buy | COGENT BIOSCIENCES INC | $40,739,025 | +45.8% | 3,440,796 | +32.9% | 0.69% | +34.3% |
BEP | BROOKFIELD RENEWABLE PARTNERpartnership unit | $36,449,640 | -6.4% | 1,236,000 | 0.0% | 0.62% | -13.8% | |
Buy | AURA BIOSCIENCES INC | $36,253,660 | +54.7% | 2,935,519 | +16.2% | 0.61% | +42.6% | |
New | TOAST INCcl a | $36,199,256 | – | 1,603,866 | +100.0% | 0.61% | – | |
APLS | Sell | APELLIS PHARMACEUTICALS INC | $36,179,545 | +10.8% | 397,141 | -19.8% | 0.61% | +2.0% |
INSP | INSPIRE MED SYS INC | $35,132,541 | +38.7% | 108,220 | 0.0% | 0.59% | +27.7% | |
HASI | Sell | HANNON ARMSTRONG SUST INFR C | $34,470,000 | -15.1% | 1,378,800 | -2.9% | 0.58% | -21.7% |
MARINUS PHARMACEUTICALS INC | $34,460,919 | +57.4% | 3,173,197 | 0.0% | 0.58% | +44.8% | ||
SNPS | Sell | SYNOPSYS INC | $34,053,852 | +10.6% | 78,211 | -1.9% | 0.58% | +1.9% |
RPRX | Sell | ROYALTY PHARMA PLC | $31,960,931 | -15.4% | 1,039,718 | -0.9% | 0.54% | -22.2% |
CDW | CDW CORP | $31,157,382 | -5.8% | 169,795 | 0.0% | 0.53% | -13.2% | |
PRTA | Buy | PROTHENA CORP PLC | $30,395,183 | +42.9% | 445,155 | +1.5% | 0.51% | +31.8% |
WDAY | Buy | WORKDAY INCcl a | $30,204,430 | +6620.6% | 133,713 | +6044.9% | 0.51% | +6275.0% |
NARI | INARI MED INC | $29,820,820 | -5.8% | 512,914 | 0.0% | 0.50% | -13.3% | |
TRGP | Buy | TARGA RES CORP | $29,813,621 | +30.6% | 391,769 | +25.2% | 0.50% | +20.3% |
KLAC | Buy | KLA CORP | $29,442,654 | +44.2% | 60,704 | +18.7% | 0.50% | +32.8% |
WMB | Buy | WILLIAMS COS INC | $29,311,757 | +39.3% | 898,307 | +27.5% | 0.50% | +28.2% |
ORLY | Buy | OREILLY AUTOMOTIVE INC | $29,081,243 | +12.6% | 30,442 | +0.1% | 0.49% | +3.6% |
BPMC | BLUEPRINT MEDICINES CORP | $27,713,200 | +40.5% | 438,500 | 0.0% | 0.47% | +29.3% | |
PRVA | PRIVIA HEALTH GROUP INC | $26,110,000 | -5.4% | 1,000,000 | 0.0% | 0.44% | -13.0% | |
ISRG | Buy | INTUITIVE SURGICAL INC | $25,665,333 | +33.9% | 75,058 | +0.0% | 0.43% | +23.3% |
SGEN | Sell | SEAGEN INC | $25,206,679 | -55.5% | 130,971 | -53.2% | 0.43% | -59.0% |
STE | Sell | STERIS PLC | $25,118,117 | -3.8% | 111,646 | -18.2% | 0.42% | -11.3% |
IRTC | IRHYTHM TECHNOLOGIES INC | $24,946,563 | -15.9% | 239,135 | 0.0% | 0.42% | -22.4% | |
IMGN | New | IMMUNOGEN INC | $24,531,000 | – | 1,300,000 | +100.0% | 0.42% | – |
BEPC | Buy | BROOKFIELD RENEWABLE CORPcl a sub vtg | $24,454,824 | -9.8% | 775,851 | +0.1% | 0.41% | -16.9% |
SHW | Buy | SHERWIN WILLIAMS CO | $24,455,720 | +68.1% | 92,105 | +42.3% | 0.41% | +54.7% |
Buy | AMYLYX PHARMACEUTICALS INC | $24,090,174 | +79.3% | 1,116,837 | +143.8% | 0.41% | +64.8% | |
PLD | Sell | PROLOGIS INC. | $23,594,993 | -13.3% | 192,408 | -11.8% | 0.40% | -20.2% |
KROS | Buy | KEROS THERAPEUTICS INC | $23,304,400 | +81.9% | 580,000 | +93.3% | 0.39% | +67.7% |
NOVT | Buy | NOVANTA INC | $23,199,730 | +15.8% | 126,017 | +0.1% | 0.39% | +6.5% |
CWEN | Sell | CLEARWAY ENERGY INCcl c | $22,030,784 | -45.8% | 771,386 | -40.5% | 0.37% | -50.1% |
MRTX | Buy | MIRATI THERAPEUTICS INC | $21,678,000 | +57.1% | 600,000 | +61.7% | 0.37% | +44.7% |
AJG | Sell | GALLAGHER ARTHUR J & CO | $21,429,812 | -6.5% | 97,599 | -18.5% | 0.36% | -13.8% |
PNR | Buy | PENTAIR PLC | $21,331,372 | +42.2% | 330,207 | +21.6% | 0.36% | +31.3% |
NTLA | INTELLIA THERAPEUTICS INC | $20,113,593 | +9.4% | 493,222 | 0.0% | 0.34% | +0.9% | |
New | HASHICORP INC | $19,612,014 | – | 749,122 | +100.0% | 0.33% | – | |
INSM | INSMED INC | $19,245,373 | +23.8% | 912,103 | 0.0% | 0.32% | +14.0% | |
CMS | Buy | CMS ENERGY CORP | $18,877,197 | +173.3% | 321,314 | +185.5% | 0.32% | +151.2% |
VCYT | VERACYTE INC | $18,644,040 | +14.2% | 732,000 | 0.0% | 0.32% | +5.4% | |
CYTK | CYTOKINETICS INC | $18,136,720 | -7.3% | 556,000 | 0.0% | 0.31% | -14.5% | |
RCKT | ROCKET PHARMACEUTICALS INC | $17,843,260 | +16.0% | 898,000 | 0.0% | 0.30% | +7.1% | |
AKRO | AKERO THERAPEUTICS INC | $17,701,113 | +22.0% | 379,120 | 0.0% | 0.30% | +12.4% | |
ALKS | New | ALKERMES PLC | $17,597,893 | – | 562,233 | +100.0% | 0.30% | – |
ROIVANT SCIENCES LTD | $17,038,224 | +36.6% | 1,690,300 | 0.0% | 0.29% | +25.8% | ||
RGEN | REPLIGEN CORP | $16,833,740 | -16.0% | 119,000 | 0.0% | 0.28% | -22.6% | |
RARE | ULTRAGENYX PHARMACEUTICAL IN | $16,560,670 | +15.0% | 359,000 | 0.0% | 0.28% | +6.1% | |
ELS | EQUITY LIFESTYLE PPTYS INC | $16,504,238 | -0.4% | 246,737 | 0.0% | 0.28% | -8.2% | |
BRKR | BRUKER CORP | $16,321,758 | -6.2% | 220,803 | 0.0% | 0.28% | -13.5% | |
BBIO | BRIDGEBIO PHARMA INC | $16,188,227 | +3.7% | 941,176 | 0.0% | 0.27% | -4.2% | |
XENE | Sell | XENON PHARMACEUTICALS INC | $15,935,381 | -30.6% | 413,906 | -35.4% | 0.27% | -36.1% |
CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $15,577,100 | +104.7% | 490,000 | +57.1% | 0.26% | +87.9% |
FANG | New | DIAMONDBACK ENERGY INC | $14,942,594 | – | 113,753 | +100.0% | 0.25% | – |
BEAM | BEAM THERAPEUTICS INC | $14,662,352 | +4.3% | 459,203 | 0.0% | 0.25% | -3.9% | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $14,241,437 | -10.9% | 164,299 | 0.0% | 0.24% | -17.7% | |
MSCI | New | MSCI INC | $14,273,455 | – | 30,415 | +100.0% | 0.24% | – |
SYY | SYSCO CORP | $14,196,909 | -3.9% | 191,333 | 0.0% | 0.24% | -11.4% | |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $14,045,076 | -45.6% | 122,643 | -34.5% | 0.24% | -50.0% |
Buy | GXO LOGISTICS INCORPORATED | $13,830,577 | +24.5% | 220,162 | +0.0% | 0.23% | +14.7% | |
BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $13,868,800 | +50.8% | 1,970,000 | +78.6% | 0.23% | +38.5% |
VRSK | Sell | VERISK ANALYTICS INC | $13,805,008 | -64.2% | 61,076 | -69.6% | 0.23% | -67.1% |
Buy | R1 RCM INC | $13,573,757 | +51.9% | 735,705 | +23.5% | 0.23% | +39.6% | |
DVAX | New | DYNAVAX TECHNOLOGIES CORP | $13,257,031 | – | 1,026,086 | +100.0% | 0.22% | – |
IEX | IDEX CORP | $13,164,010 | -6.8% | 61,154 | 0.0% | 0.22% | -14.3% | |
EHC | ENCOMPASS HEALTH CORP | $12,863,478 | +25.2% | 189,979 | 0.0% | 0.22% | +14.8% | |
NBIX | NEUROCRINE BIOSCIENCES INC | $12,730,500 | -6.8% | 135,000 | 0.0% | 0.22% | -14.3% | |
ETNB | 89BIO INC | $12,167,283 | +24.4% | 642,073 | 0.0% | 0.21% | +15.1% | |
VKTX | New | VIKING THERAPEUTICS INC | $12,157,500 | – | 750,000 | +100.0% | 0.20% | – |
ESI | Sell | ELEMENT SOLUTIONS INC | $11,493,274 | -14.2% | 598,608 | -13.7% | 0.19% | -21.1% |
RPHM | New | RENEO PHARMACEUTICALS INC | $11,480,000 | – | 1,750,000 | +100.0% | 0.19% | – |
MASS | Sell | 908 DEVICES INC | $9,816,626 | -48.8% | 1,430,995 | -35.8% | 0.17% | -52.8% |
RVMD | New | REVOLUTION MEDICINES INC | $9,646,986 | – | 360,635 | +100.0% | 0.16% | – |
DNLI | DENALI THERAPEUTICS INC | $9,248,641 | +28.1% | 313,407 | 0.0% | 0.16% | +18.2% | |
NDAQ | Sell | NASDAQ INC | $9,107,994 | -57.1% | 182,708 | -53.0% | 0.15% | -60.5% |
PTGX | New | PROTAGONIST THERAPEUTICS INC | $8,838,400 | – | 320,000 | +100.0% | 0.15% | – |
CRNX | CRINETICS PHARMACEUTICALS IN | $7,834,519 | +12.2% | 434,768 | 0.0% | 0.13% | +3.1% | |
EQIX | New | EQUINIX INC | $7,466,245 | – | 9,524 | +100.0% | 0.13% | – |
EGP | EASTGROUP PPTYS INC | $5,773,068 | +5.0% | 33,255 | 0.0% | 0.10% | -3.0% | |
TMDX | New | TRANSMEDICS GROUP INC | $5,665,374 | – | 67,461 | +100.0% | 0.10% | – |
RCUS | ARCUS BIOSCIENCES INC | $4,874,400 | +11.3% | 240,000 | 0.0% | 0.08% | +2.5% | |
IONS | IONIS PHARMACEUTICALS INC | $4,513,300 | +14.8% | 110,000 | 0.0% | 0.08% | +5.6% | |
Sell | ARTERIS INC | $2,719,639 | +23.0% | 398,774 | -23.7% | 0.05% | +12.2% | |
New | XOMETRY INCnote 1.000% 2/0 | $1,588,650 | – | 2,100,000 | +100.0% | 0.03% | – | |
New | NERDWALLET INC | $1,411,500 | – | 150,000 | +100.0% | 0.02% | – | |
NOW | Buy | SERVICENOW INC | $509,145 | +52.6% | 906 | +26.2% | 0.01% | +50.0% |
NVDA | Buy | NVIDIA CORPORATION | $519,892 | +415.6% | 1,229 | +238.6% | 0.01% | +350.0% |
COMP | New | COMPASS INCcl a | $451,076 | – | 128,879 | +100.0% | 0.01% | – |
EW | Buy | EDWARDS LIFESCIENCES CORP | $481,838 | +44.5% | 5,108 | +26.7% | 0.01% | +33.3% |
ALGN | New | ALIGN TECHNOLOGY INC | $416,588 | – | 1,178 | +100.0% | 0.01% | – |
TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $367,349 | +94.8% | 3,640 | +79.6% | 0.01% | +100.0% |
NEE | Sell | NEXTERA ENERGY INC | $234,695 | -15.3% | 3,163 | -12.0% | 0.00% | -20.0% |
MDB | Exit | MONGODB INCcl a | $0 | – | -81 | -100.0% | 0.00% | – |
DLO | Exit | DLOCAL LTDcall | $0 | – | -3,900 | -100.0% | 0.00% | – |
XPO | Exit | XPO INC | $0 | – | -208 | -100.0% | 0.00% | – |
ZI | Exit | ZOOMINFO TECHNOLOGIES INC | $0 | – | -1,067 | -100.0% | 0.00% | – |
GNRC | Exit | GENERAC HLDGS INC | $0 | – | -103 | -100.0% | 0.00% | – |
ZTS | Exit | ZOETIS INCcl a | $0 | – | -2,015 | -100.0% | -0.01% | – |
PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -34,047 | -100.0% | -0.03% | – |
FRLN | Exit | FREELINE THERAPEUTICS HLDGSsponsored ads | $0 | – | -4,702,641 | -100.0% | -0.04% | – |
Exit | RXO INC | $0 | – | -115,000 | -100.0% | -0.04% | – | |
TALS | Exit | TALARIS THERAPEUTICS INC | $0 | – | -1,561,092 | -100.0% | -0.05% | – |
ALXO | Exit | ALX ONCOLOGY HLDGS INC | $0 | – | -664,829 | -100.0% | -0.06% | – |
ADCT | Exit | ADC THERAPEUTICS SA | $0 | – | -1,675,959 | -100.0% | -0.06% | – |
Exit | NEXTERA ENERGY INCunit 09/01/2025 | $0 | – | -75,000 | -100.0% | -0.06% | – | |
ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -501,033 | -100.0% | -0.12% | – |
ANNX | Exit | ANNEXON INC | $0 | – | -1,867,250 | -100.0% | -0.13% | – |
WEC | Exit | WEC ENERGY GROUP INC | $0 | – | -94,165 | -100.0% | -0.16% | – |
APTVPRA | Exit | APTIV PLC5.5% cnv pfd a | $0 | – | -78,500 | -100.0% | -0.18% | – |
ZIP | Exit | ZIPRECRUITER INCcl a | $0 | – | -817,475 | -100.0% | -0.24% | – |
AESC | Exit | AES CORPunit 02/15/2024 | $0 | – | -156,400 | -100.0% | -0.26% | – |
BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -2,210,000 | -100.0% | -0.29% | – |
FGEN | Exit | FIBROGEN INC | $0 | – | -960,000 | -100.0% | -0.33% | – |
BILL | Exit | BILL HOLDINGS INC | $0 | – | -264,398 | -100.0% | -0.39% | – |
IMVT | Exit | IMMUNOVANT INC | $0 | – | -1,390,000 | -100.0% | -0.40% | – |
CCI | Exit | CROWN CASTLE INC | $0 | – | -235,052 | -100.0% | -0.58% | – |
VECT | Exit | VECTIVBIO HLDG AG | $0 | – | -3,675,644 | -100.0% | -0.58% | – |
ENPH | Exit | ENPHASE ENERGY INC | $0 | – | -171,081 | -100.0% | -0.66% | – |
RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -670,020 | -100.0% | -1.32% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-15
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 43 | Q2 2024 | 3.2% |
PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
VERACYTE INC | 41 | Q2 2024 | 1.5% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-11-06 |
N-PX | 2024-08-27 |
13F-HR | 2024-08-13 |
SC 13G/A | 2024-08-09 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.